Suggestions

Du même auteur

Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

Archive ouverte | Grinda, T. | CCSD

International audience. BACKGROUND: Treatment strategies for metastatic breast cancer (MBC) have made great strides over the past 10 years. Real-world data allow us to evaluate the actual benefit of new treatments. ...

Management and outcome of metastatic breast cancer in men in the national multicenter observational ESME program. : Annals of Oncology

Archive ouverte | Sirieix, J. | CCSD

International audience

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

Archive ouverte | Jacquet, E. | CCSD

International audience. BACKGROUND:For hormone receptor-positive (HR+) human epidermal growth factor receptor 2 (HER2-) negative metastatic breast cancer (MBC), international guidelines recommend endocrine therapy a...

Chargement des enrichissements...